Quick Answer
INTEGRA LIFESCIENCES HOLDINGS CORP reported Total Revenue of $1.64 billion for fiscal year 2025.
INTEGRA LIFESCIENCES HOLDINGS CORP — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $1.64B +1.5% |
$1.61B +4.5% |
$1.54B -1.0% |
$1.56B +1.0% |
$1.54B +12.4% |
$1.37B -9.6% |
| Revenue (ASC 606) | $1.64B +1.5% |
$1.61B +4.5% |
$1.54B -1.0% |
$1.56B +1.0% |
$1.54B +12.4% |
$1.37B -9.6% |
| Net Income | -$516.47M -7337.7% |
-$6.94M -110.3% |
$67.74M -62.5% |
$180.55M +6.8% |
$169.07M +26.3% |
$133.89M +166.7% |
| Diluted EPS | -$6.74 -7388.9% |
-$0.09 -110.7% |
$0.84 -61.1% |
$2.16 +9.1% |
$1.98 +26.1% |
$1.57 +170.7% |
| Total Assets | $3.60B -10.8% |
$4.04B +6.8% |
$3.78B -2.8% |
$3.89B +2.8% |
$3.78B +4.6% |
$3.62B +9.4% |
| Cash and Equivalents | $235.05M -4.6% |
$246.38M -10.9% |
$276.40M -39.5% |
$456.66M -11.1% |
$513.45M +9.2% |
$470.17M +136.4% |
| Stockholders Equity | $1.04B -32.5% |
$1.55B -2.7% |
$1.59B -12.0% |
$1.80B +7.1% |
$1.68B +11.2% |
$1.51B +6.9% |
| R&D Expense | — | — | — | — | — | — |
| Operating Income | -$493.37M -1836.5% |
$28.41M -74.5% |
$111.53M -53.3% |
$238.92M +21.1% |
$197.23M +30.3% |
$151.37M +61.4% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $402.06M | +5.6% | -3.3% |
| Revenue (ASC 606) | September 30, 2025 | $402.06M | +5.6% | -3.3% |
| Net Income | September 30, 2025 | -$5.40M | +49.5% | +98.9% |
| Diluted EPS | September 30, 2025 | -$0.07 | +50.0% | +98.9% |
| Total Assets | September 30, 2025 | $3.65B | -10.3% | -0.6% |
| Cash and Equivalents | September 30, 2025 | $232.19M | +7.9% | +6.5% |
| Stockholders Equity | September 30, 2025 | $1.04B | -31.8% | -0.1% |
| R&D Expense | June 30, 2020 | $14.93M | -15.4% | -28.3% |
| Operating Income | September 30, 2025 | $11.76M | +244.3% | +102.3% |
- INTEGRA LIFESCIENCES HOLDINGS CORP reported Total Revenue of $1.64 billion for fiscal year 2025.
- INTEGRA LIFESCIENCES HOLDINGS CORP showed an increase of +1.5% in Total Revenue compared to the prior fiscal year.
- INTEGRA LIFESCIENCES HOLDINGS CORP reported Revenue (ASC 606) of $1.64 billion for fiscal year 2025.
- INTEGRA LIFESCIENCES HOLDINGS CORP showed an increase of +1.5% in Revenue (ASC 606) compared to the prior fiscal year.
- INTEGRA LIFESCIENCES HOLDINGS CORP reported Net Income of -$516.47 million for fiscal year 2025.
- INTEGRA LIFESCIENCES HOLDINGS CORP showed a decrease of -7337.7% in Net Income compared to the prior fiscal year.
- INTEGRA LIFESCIENCES HOLDINGS CORP reported Diluted EPS of $6.74 per share (loss) for fiscal year 2025.
- INTEGRA LIFESCIENCES HOLDINGS CORP showed a decrease of -7388.9% in Diluted EPS compared to the prior fiscal year.
- INTEGRA LIFESCIENCES HOLDINGS CORP reported Total Assets of $3.60 billion for fiscal year 2025.
- INTEGRA LIFESCIENCES HOLDINGS CORP showed a decrease of -10.8% in Total Assets compared to the prior fiscal year.
- INTEGRA LIFESCIENCES HOLDINGS CORP reported Cash and Equivalents of $235.05 million for fiscal year 2025.
- INTEGRA LIFESCIENCES HOLDINGS CORP showed a decrease of -4.6% in Cash and Equivalents compared to the prior fiscal year.
- INTEGRA LIFESCIENCES HOLDINGS CORP reported Stockholders Equity of $1.04 billion for fiscal year 2025.
- INTEGRA LIFESCIENCES HOLDINGS CORP showed a decrease of -32.5% in Stockholders Equity compared to the prior fiscal year.
- INTEGRA LIFESCIENCES HOLDINGS CORP reported R&D Expense of $78.04 million for fiscal year 2018.
- INTEGRA LIFESCIENCES HOLDINGS CORP showed an increase of +23.0% in R&D Expense compared to the prior fiscal year.
- INTEGRA LIFESCIENCES HOLDINGS CORP reported Operating Income of -$493.37 million for fiscal year 2025.
- INTEGRA LIFESCIENCES HOLDINGS CORP showed a decrease of -1836.5% in Operating Income compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: